Comparison Study of Psoriasis Severity Assessment Tools

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Psoriasis
Interventions
DRUG

Cyclosporine A

Male 200 mg/day, Female 150 mg/day for 16 weeks

DRUG

Methotrexate

Initial dose with 10 mg/week, increasing 2.5 mg every 2 weeks up to 15 mg/week maintenance dose

Trial Locations (1)

KS009

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02655705 - Comparison Study of Psoriasis Severity Assessment Tools | Biotech Hunter | Biotech Hunter